This research study tests a new medicine called ziltivekimab to see if it can help people who had a heart attack. People in the study will get either ziltivekimab or a placebo (a fake medicine with no effect). Each participant will inject the medicine into the skin on their stomach, thigh, or upper arm once a month for 2 years. Ziltivekimab is not yet approved by doctors to be used as a treatment anywhere in the world. The study aims to find out if this medicine can help prevent more heart attacks or strokes.

• The study lasts about 2 years, requiring monthly medicine injections.
• Participants will be randomly assigned to receive either ziltivekimab or placebo.
• It's important to check if you meet the study's health rules before joining.